The mutation-dependent pathogenicity of NPHS2 p.R229Q

A guide for clinical assessment

Ágnes Mikó, Dóra K. Menyhárd, Ambrus Kaposi, Corinne Antignac, K. Tory

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

NPHS2, encoding podocin, is the major gene implicated in steroid-resistant nephrotic syndrome. Its c.686G>A, p.R229Q variant is the first human variant with a mutation-dependent pathogenicity; it is only pathogenic when trans-associated to specific mutations. Secondary to its high allele frequency in the European, South Asian, African, and Latino populations, its benign trans-associations can be accidentally identified in affected patients. Distinguishing pathogenic and benign p.R229Q associations can be challenging. In this paper, we present the currently known pathogenic and benign associations, and show that a rare p.R229Q association can be considered pathogenic if the variant in trans meets the following criteria; it affects the 270–351 residues and alters but does not disrupt the oligomerization, its p.R229Q association is found in a family with slowly progressing focal segmental glomerulosclerosis, but is expected to be rare in the general population (<1:106). We show that >15% of the p.R229Q associations identified so far in patients are benign.

Original languageEnglish
JournalHuman Mutation
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Virulence
Focal Segmental Glomerulosclerosis
Mutation
Nephrotic Syndrome
Hispanic Americans
Gene Frequency
Population
Steroids
Genes
NPHS2 protein

Keywords

  • dominant
  • interallelic interactions
  • negative
  • nephrotic syndrome
  • NPHS2
  • podocin
  • population genetics

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

The mutation-dependent pathogenicity of NPHS2 p.R229Q : A guide for clinical assessment. / Mikó, Ágnes; K. Menyhárd, Dóra; Kaposi, Ambrus; Antignac, Corinne; Tory, K.

In: Human Mutation, 01.01.2018.

Research output: Contribution to journalArticle

Mikó, Ágnes ; K. Menyhárd, Dóra ; Kaposi, Ambrus ; Antignac, Corinne ; Tory, K. / The mutation-dependent pathogenicity of NPHS2 p.R229Q : A guide for clinical assessment. In: Human Mutation. 2018.
@article{2dd36ce69f4a45fe9d17959a69f98dc4,
title = "The mutation-dependent pathogenicity of NPHS2 p.R229Q: A guide for clinical assessment",
abstract = "NPHS2, encoding podocin, is the major gene implicated in steroid-resistant nephrotic syndrome. Its c.686G>A, p.R229Q variant is the first human variant with a mutation-dependent pathogenicity; it is only pathogenic when trans-associated to specific mutations. Secondary to its high allele frequency in the European, South Asian, African, and Latino populations, its benign trans-associations can be accidentally identified in affected patients. Distinguishing pathogenic and benign p.R229Q associations can be challenging. In this paper, we present the currently known pathogenic and benign associations, and show that a rare p.R229Q association can be considered pathogenic if the variant in trans meets the following criteria; it affects the 270–351 residues and alters but does not disrupt the oligomerization, its p.R229Q association is found in a family with slowly progressing focal segmental glomerulosclerosis, but is expected to be rare in the general population (<1:106). We show that >15{\%} of the p.R229Q associations identified so far in patients are benign.",
keywords = "dominant, interallelic interactions, negative, nephrotic syndrome, NPHS2, podocin, population genetics",
author = "{\'A}gnes Mik{\'o} and {K. Menyh{\'a}rd}, D{\'o}ra and Ambrus Kaposi and Corinne Antignac and K. Tory",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/humu.23660",
language = "English",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - The mutation-dependent pathogenicity of NPHS2 p.R229Q

T2 - A guide for clinical assessment

AU - Mikó, Ágnes

AU - K. Menyhárd, Dóra

AU - Kaposi, Ambrus

AU - Antignac, Corinne

AU - Tory, K.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - NPHS2, encoding podocin, is the major gene implicated in steroid-resistant nephrotic syndrome. Its c.686G>A, p.R229Q variant is the first human variant with a mutation-dependent pathogenicity; it is only pathogenic when trans-associated to specific mutations. Secondary to its high allele frequency in the European, South Asian, African, and Latino populations, its benign trans-associations can be accidentally identified in affected patients. Distinguishing pathogenic and benign p.R229Q associations can be challenging. In this paper, we present the currently known pathogenic and benign associations, and show that a rare p.R229Q association can be considered pathogenic if the variant in trans meets the following criteria; it affects the 270–351 residues and alters but does not disrupt the oligomerization, its p.R229Q association is found in a family with slowly progressing focal segmental glomerulosclerosis, but is expected to be rare in the general population (<1:106). We show that >15% of the p.R229Q associations identified so far in patients are benign.

AB - NPHS2, encoding podocin, is the major gene implicated in steroid-resistant nephrotic syndrome. Its c.686G>A, p.R229Q variant is the first human variant with a mutation-dependent pathogenicity; it is only pathogenic when trans-associated to specific mutations. Secondary to its high allele frequency in the European, South Asian, African, and Latino populations, its benign trans-associations can be accidentally identified in affected patients. Distinguishing pathogenic and benign p.R229Q associations can be challenging. In this paper, we present the currently known pathogenic and benign associations, and show that a rare p.R229Q association can be considered pathogenic if the variant in trans meets the following criteria; it affects the 270–351 residues and alters but does not disrupt the oligomerization, its p.R229Q association is found in a family with slowly progressing focal segmental glomerulosclerosis, but is expected to be rare in the general population (<1:106). We show that >15% of the p.R229Q associations identified so far in patients are benign.

KW - dominant

KW - interallelic interactions

KW - negative

KW - nephrotic syndrome

KW - NPHS2

KW - podocin

KW - population genetics

UR - http://www.scopus.com/inward/record.url?scp=85055265332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055265332&partnerID=8YFLogxK

U2 - 10.1002/humu.23660

DO - 10.1002/humu.23660

M3 - Article

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

ER -